Johnny Powers
Directeur/Membre du Conseil chez ZOMEDICA CORP.
Fortune : 324 850 $ au 30/06/2024
Profil
Johnny D.
Powers is the founder of Jd Powers Consulting Group.
He is currently working as an Independent Director at Zomedica Corp.
He previously worked as a Director at Organon Teknika Corp.
LLC from 1989 to 1996.
Dr. Powers also served as the Vice President-Cancer Diagnostics business at Becton, Dickinson & Co. from 2007 to 2008.
From 2009 to 2016, he held the position of Executive Vice President at IDEXX Laboratories, Inc. .
Additionally, Dr. Powers worked as the Vice President & GM-Manufacturing Operations at Ventana Medical Systems, Inc. from 1996 to 2001.
He was also the President of TriPath Oncology, Inc. from 2001 to 2007.
In terms of education, Dr. Powers obtained his undergraduate degree from Wake Forest University in 1983.
He then pursued a graduate degree from Clemson University in 1985.
Powers further earned a doctorate degree from North Carolina State University in 1989.
Lastly, he completed his MBA from The Fuqua School of Business in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZOMEDICA CORP
0,23% | 17/05/2024 | 2 225 000 ( 0,23% ) | 324 850 $ | 30/06/2024 |
Postes actifs de Johnny Powers
| Sociétés | Poste | Début |
|---|---|---|
| ZOMEDICA CORP. | Directeur/Membre du Conseil | 16/08/2019 |
| Jd Powers Consulting Group | Fondateur | - |
Anciens postes connus de Johnny Powers
| Sociétés | Poste | Fin |
|---|---|---|
| IDEXX LABORATORIES, INC. | Corporate Officer/Principal | 08/02/2016 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/01/2008 |
TriPath Oncology, Inc.
 TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | President | 01/01/2007 |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | 01/01/2001 |
Organon Teknika Corp. LLC
 Organon Teknika Corp. LLC Financial ConglomeratesFinance Part of Merck & Co., Inc., Organon Teknika Corp. LLC is an American company led by the management of PerImmune. | Directeur/Membre du Conseil | 01/01/1996 |
Formation de Johnny Powers
| Wake Forest University | Undergraduate Degree |
| Clemson University | Graduate Degree |
| North Carolina State University | Doctorate Degree |
| The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| IDEXX LABORATORIES, INC. | Health Technology |
| ZOMEDICA CORP. | Health Technology |
| Entreprise privées | 4 |
|---|---|
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Commercial Services |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Organon Teknika Corp. LLC
Organon Teknika Corp. LLC Financial ConglomeratesFinance Part of Merck & Co., Inc., Organon Teknika Corp. LLC is an American company led by the management of PerImmune. | Finance |
| Jd Powers Consulting Group |
